Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Pancreatic stem cells--a new therapeutic option for the treatment of type 1 diabetes mellitus?].

Therapeutische Umschau. Revue therapeutique - 1 Nov 2002

Zulewski H

Abstract excerpt

The recent discovery of heretofore unknown, multipotential stem cells within the embryonic and adult islets of Langerhans suggests new therapeutic options for the treatment of diabetes mellitus type 1. These cells are characterised by the expression of the neural stem cell marker nestin and by their ability to differentiate ex vivo into pancreatic endocrine, exocrine and hepatic phenotypes with the expression of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Fetoproteins
Share to Amylases
Share to Glucagon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin Secretion

Share to Intermediate Filament Proteins

Share to Keratins

Share to Multipotent Stem Cells

Share to Nestin

Source

Identifiers

PMID: 12498053
DOI: 10.1024/0040-5930.59.11.599

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Pancreatic stem cells--a new therapeutic option for the treatment of type 1 diabetes mellitus?].PMID 12498053Read ↗

Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes.Semantic proximity Read ↗

Stem cells as a therapeutic target for diabetesSemantic proximity Read ↗

Pancreatic stem cellsSemantic proximity Read ↗

Adult pancreas generates multipotent stem cells and pancreatic and nonpancreatic progeny.Semantic proximity Read ↗

Insulin-producing cells.Semantic proximity Read ↗

Stem cell approaches for diabetes: towards beta cell replacementSemantic proximity Read ↗

Pancreatic Stem Cells Remain UnresolvedSemantic proximity Read ↗

Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment?Semantic proximity Read ↗

Insulin-Producing Cells Derived from Human Embryonic Stem Cells: Comparison of Definitive Endoderm- and Nestin-Positive Progenitor-Based Differentiation StrategiesSemantic proximity Read ↗

Stem Cells to Pancreatic β-Cells: New Sources for Diabetes Cell TherapySemantic proximity Read ↗

Generation of Insulin-Producing Islet-Like Clusters from Human Embryonic Stem CellsSemantic proximity Read ↗

The prospect of induced pluripotent stem cells for diabetes mellitus treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.